Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Nov 24;375(21):2102.
doi: 10.1056/NEJMc1610828.

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

Kenneth B Gordon  1 , Jean-Frederic Colombel  2 , Dana S Hardin  3
Affiliations
Comment

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

Kenneth B Gordon et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
    Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, Reich K, Amato D, Ball SG, Braun DK, Cameron GS, Erickson J, Konrad RJ, Muram TM, Nickoloff BJ, Osuntokun OO, Secrest RJ, Zhao F, Mallbris L, Leonardi CL; UNCOVER-1 Study Group; UNCOVER-2 Study Group; UNCOVER-3 Study Group. Gordon KB, et al. N Engl J Med. 2016 Jul 28;375(4):345-56. doi: 10.1056/NEJMoa1512711. Epub 2016 Jun 8. N Engl J Med. 2016. PMID: 27299809 Clinical Trial.
  • Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
    Egeberg A. Egeberg A. N Engl J Med. 2016 Nov 24;375(21):2101-2102. doi: 10.1056/NEJMc1610828. N Engl J Med. 2016. PMID: 27959739 No abstract available.